XL844
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for XL844, covering 2008-06-04 to 2015-08-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies [Phase 1]